title: Co-morbid condition as an important factor influencing depression treatment.
abstract: There are different factors influencing the treatment of depression. An important factor is co-morbidity. We made an analysis of depression treatment within general practice in Estonia as part of the PREDICT study in 2003-2005. The study group consisted of consecutive patients (n=1094), aged 18-75 years, who sought consultation from their family doctor. We found that more antidepressants, anxiolytics, and hypnotics were prescribed to patients with co-morbid mental disorder (odds ratio [95% confidence interval] 5.49 [3.61-8.40], 8.38 [5.33-13.18], and 4.02 [2.30-7.02], respectively) compared to those patients who did not have this disorder.
authors.forename: Kadri
authors.initials: K
authors.lastname: Suija
authors.forename: Ruth
authors.initials: R
authors.lastname: Kalda
authors.forename: Heidi-Ingrid
authors.initials: HI
authors.lastname: Maaroos
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D014151:Anti-Anxiety Agents / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000627:therapeutic use; D003863:Depression / Q000150:complications / Q000188:drug therapy*; D004957:Estonia; D058006:General Practice / Q000706:statistics & numerical data; D006801:Humans; D006993:Hypnotics and Sedatives / Q000627:therapeutic use; D001523:Mental Disorders / Q000150:complications / Q000188:drug therapy*; D008875:Middle Aged; D010818:Practice Patterns, Physicians' / Q000706:statistics & numerical data*; D055815:Young Adult
chemical_list: D014151:Anti-Anxiety Agents; D000928:Antidepressive Agents; D006993:Hypnotics and Sedatives